EBAA
We restore sight worldwide
BACKGROUND The Medical Review Subcommittee (MRS) of the EBAA Medical Advisory Board was notified of a potential rabies transmission in a kidney recipient following their December 2024 transplant. The recipient […]
The Policy & Position Review Subcommittee (PPRS) of the EBAA Medical Advisory Board continues to review its guidance and screening recommendations regarding COVID-19. Given that COVID-19 is now endemic in […]
The FDA has announced a revised implementation date of May 4, 2025, for its recently issued guidance documents: While the guidance documents remain final, FDA’s decision to delay implementation reflects a […]
The Policy & Position Review Subcommittee (PPRS) of the EBAA Medical Advisory Board has reviewed the currently available evidence regarding Chagas disease and eye tissue donation. As Chagas disease becomes […]
BACKGROUND Several recent FDA inspections of eye banks have resulted in Form FDA 483, Inspectional Observations, for not determining donors to be ineligible with a diagnosis of sepsis. All cited […]
Eye Safety Tips for the 2024 Total Eclipse On Monday, April 8, 2024 parts of the southern and eastern United States are set to experience a total solar eclipse and […]
On May 5, EBAA alerted the membership about a critical supply issue with the BioRad HIV 1/2 Plus O EIA Assay through an All Member post in The Lens. Two […]
The Policy and Position Review Subcommittee (PPRS) of the EBAA Medical Advisory Board has reassessed what is currently known about the risk of transmission of Human T-lymphotropic virus (HTLV) via […]
EBAA Regulatory Alert: FDA Releases Important Information for HCT/P Establishments Regarding Monkeypox Virus and HCT/P Donation August 29, 2022 FDA released a new safety communication for human cells, tissues, or cellular or […]
360 Partners enjoy year-round access to EBAA members
